The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration-Reference-Cited by-同舟云学术

The Need for Serum Testosterone Measurement with Liquid Chromatography and Tandem Mass Spectrometry in Prostate Cancer Patients Undergoing Castration

Published:2023-09 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Morote Juan^ORCID,Aguilar Adriana,Trilla Enrique

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference5 articles.

1. Mottet M, Cornford P, van den Bergh RCN, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Arnhem, The Netherlands: European Association of Urology; 2023. http://uroweb.org/guideline/prostate-cancer/.

2. Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making;Oefelein;Urology,2000

3. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement;Rosner;J Clin Endocrinol Metab,2007

4. Serum testosterone levels in prostate cancer patients undergoing luteinizing hormone-releasing hormone agonist therapy;Morote;Clin Genitourin Cancer,2018

5. Serum testosterone measured by liquid chromatography-tandem mass spectrometry is an independent predictor of response to castration in metastatic hormone-sensitive prostate cancer;van Winden;Clin Chim Acta,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Testosterone Extraction from Human Plasma Using MOFs (MIL-53(Al) and ZIF-8)-Based D-µ-SPE Coupled to HPLC–UV;Chromatographia;2024-04-22